Postnatal Cardiac Gene Editing Using CRISPR/Cas9 With AAV9-Mediated Delivery of Short Guide RNAs Results in Mosaic Gene Disruption
暂无分享,去创建一个
L. Zentilin | M. Giacca | B. Spanjaard | B. Molenaar | D. Versteeg | H. de Ruiter | E. van Rooij | A. K. Johansen | Ana Rita Canhoto Leitoguinho | L. Kooijman | C. Demkes | Farhad Akbari Moqadam
[1] Abdullahi Umar Ibrahim,et al. Genome Engineering Using the CRISPR Cas9 System , 2019 .
[2] Guocheng Yuan,et al. Analysis of Cardiac Myocyte Maturation Using CASAAV, a Platform for Rapid Dissection of Cardiac Myocyte Gene Function In Vivo , 2017, Circulation research.
[3] Yan Wang,et al. Genome editing with CRISPR/Cas9 in postnatal mice corrects PRKAG2 cardiac syndrome , 2016, Cell Research.
[4] A. May,et al. DNA Repair Profiling Reveals Nonrandom Outcomes at Cas9-Mediated Breaks. , 2016, Molecular cell.
[5] John M. Shelton,et al. Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy , 2016, Science.
[6] George M. Church,et al. In vivo gene editing in dystrophic mouse muscle and muscle stem cells , 2016, Science.
[7] Dongsheng Duan,et al. In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy , 2016, Science.
[8] L. Zentilin,et al. A mouse model for adult cardiac-specific gene deletion with CRISPR/Cas9 , 2015, Proceedings of the National Academy of Sciences.
[9] R. Tjian,et al. Dynamics of CRISPR-Cas9 genome interrogation in living cells , 2015, Science.
[10] Mukul S. Bansal,et al. A comparative encyclopedia of DNA elements in the mouse genome , 2014, Nature.
[11] A. Oudenaarden,et al. Genome-wide RNA Tomography in the Zebrafish Embryo , 2014, Cell.
[12] Feng Zhang,et al. In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9 , 2014, Nature Biotechnology.
[13] Francisco J. Sánchez-Rivera,et al. Rapid modeling of cooperating genetic events in cancer through somatic genome editing , 2014, Nature.
[14] Robert Langer,et al. CRISPR-Cas9 Knockin Mice for Genome Editing and Cancer Modeling , 2014, Cell.
[15] Daniel J. Rader,et al. Permanent Alteration of PCSK9 With In Vivo CRISPR-Cas9 Genome Editing , 2014, Circulation research.
[16] R. Jaenisch,et al. Generating genetically modified mice using CRISPR/Cas-mediated genome engineering , 2014, Nature Protocols.
[17] M. Jinek,et al. Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease , 2014, Nature.
[18] Hao Yin,et al. CRISPR-mediated direct mutation of cancer genes in the mouse liver , 2014, Nature.
[19] L. Zentilin,et al. Adeno-Associated Virus Vectors as Therapeutic and Investigational Tools in the Cardiovascular System , 2014, Circulation research.
[20] Randy L. Johnson,et al. Hippo signaling impedes adult heart regeneration , 2013, Development.
[21] Eli J. Fine,et al. DNA targeting specificity of RNA-guided Cas9 nucleases , 2013, Nature Biotechnology.
[22] James E. DiCarlo,et al. RNA-Guided Human Genome Engineering via Cas9 , 2013, Science.
[23] Le Cong,et al. Multiplex Genome Engineering Using CRISPR/Cas Systems , 2013, Science.
[24] L. Zentilin,et al. Terminal differentiation of cardiac and skeletal myocytes induces permissivity to AAV transduction by relieving inhibition imposed by DNA damage response proteins. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.
[25] J. Doudna,et al. A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity , 2012, Science.
[26] T. Doetschman,et al. Cardiac-specific inducible and conditional gene targeting in mice. , 2012, Circulation research.
[27] James J. Lee,et al. The construction of transgenic and gene knockout/knockin mouse models of human disease , 2012, Transgenic Research.
[28] G. Wang,et al. Tbx20 regulates a genetic program essential to adult mouse cardiomyocyte function. , 2011, The Journal of clinical investigation.
[29] Randy L. Johnson,et al. Hippo Pathway Inhibits Wnt Signaling to Restrain Cardiomyocyte Proliferation and Heart Size , 2011, Science.
[30] P. Ping,et al. Specialized compartments of cardiac nuclei exhibit distinct proteomic anatomy* , 2011, Molecular & Cellular Proteomics.
[31] Ju-Seog Lee,et al. Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver , 2010, Proceedings of the National Academy of Sciences.
[32] Y. Pinto,et al. Avoidance of Transient Cardiomyopathy in Cardiomyocyte-Targeted Tamoxifen-Induced MerCreMer Gene Deletion Models , 2009, Circulation research.
[33] Anna Velander Gisslén,et al. Reference List , 2006, Mammalian Genome.
[34] Milena B. Furtado,et al. Murine T-box transcription factor Tbx20 acts as a repressor during heart development, and is essential for adult heart integrity, function and adaptation , 2005, Development.
[35] L. Zentilin,et al. Induction of functional neovascularization by combined VEGF and angiopoietin-1 gene transfer using AAV vectors. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.
[36] L. Zentilin,et al. Involvement of Cellular Double-Stranded DNA Break Binding Proteins in Processing of the Recombinant Adeno-Associated Virus Genome , 2001, Journal of Virology.
[37] M. Franklin,et al. Cardiomyocyte DNA synthesis and binucleation during murine development. , 1996, The American journal of physiology.
[38] T. Hewett,et al. Ablation of the murine alpha myosin heavy chain gene leads to dosage effects and functional deficits in the heart. , 1996, The Journal of clinical investigation.
[39] Feng Zhang,et al. Genome engineering using CRISPR-Cas9 system. , 2015, Methods in molecular biology.
[40] T. Borg,et al. Structural and functional characterisation of cardiac fibroblasts. , 2005, Cardiovascular research.
[41] K. Musunuru,et al. Permanent Alteration of PCSK 9 With In Vivo CRISPR-Cas 9 Genome Editing , 2022 .